Skip to main content

Systemic Antibiotic Therapy

  • Chapter
  • First Online:
Infection in Knee Replacement

Abstract

Application of systemic antibiotics plays an important role in the perioperative management of knee revision arthroplasty. Concepts may vary, depending on the corresponding surgical approach and the underlying pathogen. Biofilm prevention or disruption for example requires an appropriate and well-timed application of antibiotics. The management of PJI is an interdisciplinary approach including orthopedic surgeons, microbiologists, and infection specialists. Sometimes plastic surgeons or wound specialist need to be consulted as well.

The present chapter provides an overview of systemic antibiotic treatment in context of surgical management, concepts for empirical and focused therapy, as well as pathogen-specific considerations. The summary of the recommended management is given in the table to help clinicians to choose the right treatment regimen depending on the individual requirements in their particular cases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Karczewski D, et al. A standardized interdisciplinary algorithm for the treatment of prosthetic joint infections. Bone Joint J. 2019;101-B(2):132–9.

    Article  CAS  PubMed  Google Scholar 

  2. Li HK, et al. Oral versus intravenous antibiotics for bone and joint infection. N Engl J Med. 2019;380(5):425–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Li HK, et al. Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trial. Trials. 2015;16(1):583.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Li C, Renz N, Trampuz A. Management of periprosthetic joint infection. Hip Pelvis. 2018;30(3):138–46.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Trampuz A, Zimmerli W. New strategies for the treatment of infections associated with prosthetic joints. Curr Opin Investig Drugs. 2005;6(2):185–90.

    CAS  PubMed  Google Scholar 

  6. Kunutsor SK, et al. Debridement, antibiotics and implant retention for periprosthetic joint infections: a systematic review and meta-analysis of treatment outcomes. J Infect. 2018;77(6):479–88.

    Article  PubMed  Google Scholar 

  7. Moreno MG, Trampuz A, Di Luca M. Synergistic antibiotic activity against planktonic and biofilm-embedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis. J Antimicrob Chemother. 2017;72:3085–92.

    Article  CAS  Google Scholar 

  8. Paluch E, et al. Prevention of biofilm formation by quorum quenching. Appl Microbiol Biotechnol. 2020;104(5):1871–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. McConoughey SJ, et al. Biofilms in periprosthetic orthopedic infections. Future Microbiol. 2014;9(8):987–1007.

    Article  CAS  PubMed  Google Scholar 

  10. Parvizi J, Ghazavi M, M.O.P.-O.A. Committee of the Consensus Meeting. Optimal timing and antibiotic prophylaxis in periprosthetic joint infection (PJI): literature review and world consensus (part three). Shafa Ortho J. 2014;2(3).

    Google Scholar 

  11. Wouthuyzen-Bakker M, et al. Withholding preoperative antibiotic prophylaxis in knee prosthesis revision: a retrospective analysis on culture results and risk of infection. J Arthroplasty. 2017;32(9):2829–33.

    Article  PubMed  Google Scholar 

  12. Wimmer MD, et al. Evaluation of an interdisciplinary therapy algorithm in patients with prosthetic joint infections. Int Orthop. 2013;37(11):2271–8.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Liang SY, Kumar A. Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance. Curr Infect Dis Rep. 2015;17(7):493.

    Article  PubMed  PubMed Central  Google Scholar 

  14. W-Dahl A, et al. Timing of preoperative antibiotics for knee arthroplasties: improving the routines in Sweden. Patient Saf Surg. 2011;5:22.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Dellinger EP. Prophylactic antibiotics: administration and timing before operation are more important than administration after operation. Clin Infect Dis. 2007;44(7):928–30.

    Article  PubMed  Google Scholar 

  16. Izakovicova P, Borens O, Trampuz A. Periprosthetic joint infection: current concepts and outlook. EFORT Open Rev. 2019;4(7):482–94.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Widmer AF, et al. Killing of nongrowing and adherent Escherichia Coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother. 1991;35(4):741–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Osmon DR, Berbari EF, Berendt AR. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):e1–e25.

    Article  PubMed  Google Scholar 

  19. Tande AJ, et al. Prosthetic joint infection. Clin Microbiol Rev. 2014;27(2):302–45.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Anemuller R, et al. Hip and knee section, treatment, antimicrobials: proceedings of international consensus on orthopedic infections. J Arthroplasty. 2019;34(2S):S463–75.

    Article  PubMed  Google Scholar 

  21. Rakow A, et al. Origin and characteristics of haematogenous periprosthetic joint infection. Clin Microbiol Infect. 2019;25(7):845–50.

    Article  CAS  PubMed  Google Scholar 

  22. Ueng SW, et al. Antibacterial activity of joint fluid in cemented total-knee arthroplasty: an in vivo comparative study of polymethylmethacrylate with and without antibiotic loading. Antimicrob Agents Chemother. 2012;56(11):5541–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Parikh MS, Antony S. A comprehensive review of the diagnosis and management of prosthetic joint infections in the absence of positive cultures. J Infect Public Health. 2016;9(5):545–56.

    Article  PubMed  Google Scholar 

  24. Sousa R, et al. Empirical antibiotic therapy in prosthetic joint infections. Acta Orthop Belg. 2010;76(2):254–9.

    PubMed  Google Scholar 

  25. Molina-Manso D, et al. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections. Int J Antimicrob Agents. 2013;41(6):521–3.

    Article  CAS  PubMed  Google Scholar 

  26. Gehrke T, Alijanipour P, Parvizi J. The management of an infected total knee arthroplasty. Bone Joint J. 2015;97-B(10 Suppl A):20–9.

    Article  CAS  PubMed  Google Scholar 

  27. Geipel U, Herrmann M. Das infizierte Implantat. Orthopade. 2004;33(12):1411–28.

    Article  CAS  PubMed  Google Scholar 

  28. Tande AJ, et al. Management of prosthetic joint infection. Infect Dis Clin North Am. 2017;31(2):237–52.

    Article  PubMed  Google Scholar 

  29. Byren I, et al. One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother. 2009;63(6):1264–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Thakrar RR, et al. Indications for a single-stage exchange arthroplasty for chronic prosthetic joint infection: a systematic review. Bone Joint J. 2019;101-B(1_Supple_A):19–24.

    Article  CAS  PubMed  Google Scholar 

  31. Voigt J, Mosier M, Darouiche R. Antibiotics and antiseptics for preventing infection in people receiving revision total hip and knee prostheses: a systematic review of randomized controlled trials. BMC Infect Dis. 2016;16(1):749.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Tan TL, et al. Is vancomycin-only prophylaxis for patients with penicillin allergy associated with increased risk of infection after arthroplasty? Clin Orthop Relat Res. 2016;474(7):1601–6.

    Article  PubMed  Google Scholar 

  33. Kheir MM, et al. Vancomycin prophylaxis for total joint arthroplasty: incorrectly dosed and has a higher rate of periprosthetic infection than Cefazolin. Clin Orthop Relat Res. 2017;475(7):1767–74.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Haagensen J, et al. Spatiotemporal pharmacodynamics of Meropenem- and tobramycin-treated Pseudomonas Aeruginosa biofilms. J Antimicrob Chemother. 2017;72(12):3357–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Achermann Y, et al. Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study. Infection. 2013;41(2):431–7.

    Article  CAS  PubMed  Google Scholar 

  36. Tice AD, Hoaglund PA, Shoultz DA. Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. Am J Med. 2003;114(9):723–8.

    Article  CAS  PubMed  Google Scholar 

  37. Roy R, et al. Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action. Virulence. 2018;9(1):522–54.

    Article  CAS  PubMed  Google Scholar 

  38. Yan CH, et al. Team approach: the management of infection after total knee replacement. JBJS Rev. 2018;6(4):e9.

    Article  PubMed  Google Scholar 

  39. Dodson CC, et al. Propionibacterium acnes infection after shoulder arthroplasty: a diagnostic challenge. J Shoulder Elbow Surg. 2010;19(2):303–7.

    Article  PubMed  Google Scholar 

  40. Jakobs O, et al. Fungal periprosthetic joint infection in total knee arthroplasty: a systematic review. Orthop Rev (Pavia). 2015;7(1):5623.

    Article  Google Scholar 

  41. Keuning MC, Al Moujahid A, Zijlstra WP. Prosthetic joint infection of a revision knee arthroplasty with Candida parapsilosis. Case Rep Orthop. 2019;2019:3634519.

    PubMed  PubMed Central  Google Scholar 

  42. Prendki V, et al. Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study. Eur J Clin Microbiol Infect Dis. 2017;36(9):1577–85.

    Article  CAS  PubMed  Google Scholar 

  43. Della Valle C, et al. American Academy of Orthopaedic surgeons clinical practice guideline on: the diagnosis of periprosthetic joint infections of the hip and knee. J Bone Joint Surg Am. 2011;93(14):1355–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philip P. Roessler .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 ISAKOS

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Roessler, P.P., Hischebeth, G.T.R., Gravius, S. (2022). Systemic Antibiotic Therapy. In: Longo, U.G., Budhiparama, N.C., Lustig, S., Becker, R., Espregueira-Mendes, J. (eds) Infection in Knee Replacement. Springer, Cham. https://doi.org/10.1007/978-3-030-81553-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-81553-0_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-81552-3

  • Online ISBN: 978-3-030-81553-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics